Tuberculin screening, also known as the Mantoux tuberculin test, is one of the intradermal injections (ID) that is typically performed. Individuals who should receive testing include people known or suspected of tuberculosis and people who live or work in a community with high rates of tuberculosis, such as long-term care facilities, prisons, and homeless shelters.
Allergy testing is another reason why an ID injection is given. When this test is performed, a small volume of allergen solution is injected into the dermis layer. An intradermal allergy test is completed when the skin prick test presents with a negative result; however, the substance is still suspected as an allergen. The intradermal test is more sensitive than the skin prick test.
ID medications are injected into the dermis layer of the skin because they are potent, and the dermis contains less blood supply. This allows for a more gradual absorption of the medication.
Skin testing sites need to be in areas that can be easily assessed for color changes and reactions. The location needs to be in an area with little hair, light pigmentation, and clear of previous lesions. Typical locations include the inner forearm and upper back.
A 1mL syringe is used for the administration of intradermal medication. Since little solution is needed, 1mL syringes are used because they are calibrated in small increments.
To access the dermis layer of the skin, an angle of 5 to 15 degrees is used. It is also important to make sure that the bevel of the needle is pointed up.
As the medication is injected into the skin, a small skin color bump should appear on the skin's surface. If a bleb does not develop or if the site bleeds, it is likely the medication was injected into the subcutaneous layer.
Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.
*Average video play time: 2-3 minutes
Unforgettable characters with concise but impactful videos (2-4 min each)